Drs. Nate Pennell, Mary Pinder, and Jack West discuss an encouraging study of dabrafenib, a BRAF inhibitor, for the limited number of NSCLC patients with a BRAF V600E mutation.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
